Your browser doesn't support javascript.
loading
Response to 5-azacytidine in a patient with TET2-mutated angioimmunoblastic T-cell lymphoma and chronic myelomonocytic leukaemia preceded by an EBV-positive large B-cell lymphoma.
Saillard, Colombe; Guermouche, Helene; Derrieux, Coralie; Bruneau, Julie; Frenzel, Laurent; Couronne, Lucile; Asnafi, Vahid; Macintyre, Elizabeth; Trinquand, Amélie; Lhermitte, Ludovic; Molina, Thierry; Suarez, Felipe; Lemonnier, Francois; Kosmider, Olivier; Delarue, Richard; Hermine, Olivier; Cheminant, Morgane.
Afiliação
  • Saillard C; Clinical Hematology, IMAGINE Institute, Paris Descartes-Sorbonne Paris Cité University, Necker Hospital, AP-HP, Paris, France.
  • Guermouche H; Biological Hematology, Paris Descartes-Sorbonne Paris Cité University, Cochin Hospital, AP-HP, Paris, France.
  • Derrieux C; Biological Hematology, Paris Descartes-Sorbonne Paris Cité University, Necker Hospital, AP-HP, Paris, France.
  • Bruneau J; Department of Pathology, Imagine Institute, Paris Descartes-Sorbonne Paris Cité University, Necker Hospital, AP-HP, Paris, France.
  • Frenzel L; Clinical Hematology, IMAGINE Institute, Paris Descartes-Sorbonne Paris Cité University, Necker Hospital, AP-HP, Paris, France.
  • Couronne L; Clinical Hematology, IMAGINE Institute, Paris Descartes-Sorbonne Paris Cité University, Necker Hospital, AP-HP, Paris, France.
  • Asnafi V; INSERM UMR 1163 and CNRS ERL 8254, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, Imagine Institute, Paris, France.
  • Macintyre E; Biological Hematology, Paris Descartes-Sorbonne Paris Cité University, Necker Hospital, AP-HP, Paris, France.
  • Trinquand A; Biological Hematology, Paris Descartes-Sorbonne Paris Cité University, Necker Hospital, AP-HP, Paris, France.
  • Lhermitte L; Biological Hematology, Paris Descartes-Sorbonne Paris Cité University, Necker Hospital, AP-HP, Paris, France.
  • Molina T; Biological Hematology, Paris Descartes-Sorbonne Paris Cité University, Necker Hospital, AP-HP, Paris, France.
  • Suarez F; Department of Pathology, Imagine Institute, Paris Descartes-Sorbonne Paris Cité University, Necker Hospital, AP-HP, Paris, France.
  • Lemonnier F; Clinical Hematology, IMAGINE Institute, Paris Descartes-Sorbonne Paris Cité University, Necker Hospital, AP-HP, Paris, France.
  • Kosmider O; INSERM UMR 1163 and CNRS ERL 8254, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, Imagine Institute, Paris, France.
  • Delarue R; Clinical Hematology, IMAGINE Institute, Paris Descartes-Sorbonne Paris Cité University, Necker Hospital, AP-HP, Paris, France.
  • Hermine O; Biological Hematology, Paris Descartes-Sorbonne Paris Cité University, Cochin Hospital, AP-HP, Paris, France.
  • Cheminant M; Clinical Hematology, IMAGINE Institute, Paris Descartes-Sorbonne Paris Cité University, Necker Hospital, AP-HP, Paris, France.
Hematol Oncol ; 35(4): 864-868, 2017 Dec.
Article em En | MEDLINE | ID: mdl-27353473
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Azacitidina / Leucemia Mielomonocítica Crônica / Linfoma de Células B / Linfoma de Células T Limite: Aged80 / Female / Humans Idioma: En Revista: Hematol Oncol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Azacitidina / Leucemia Mielomonocítica Crônica / Linfoma de Células B / Linfoma de Células T Limite: Aged80 / Female / Humans Idioma: En Revista: Hematol Oncol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: França